Nasacort and Zomig drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasacort (triamcinolone acetonide) and Zomig (zolmitriptan). Common drug interactions include hypotension among females and agranulocytosis among males.

The phase IV clinical study analyzes what interactions people have when they take Nasacort and Zomig. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

What is Zomig?

Zomig has active ingredients of zolmitriptan. It is often used in migraine. eHealthMe is studying from 7,356 Zomig users. Check the latest studies of Zomig.

On Jul, 09, 2026

39 people who take Nasacort and Zomig together, and have interactions are studied.

What are the common drug interactions of Nasacort and Zomig, by gender? *:

female:

Hypotension (abnormally low blood pressure)
Hysterectomy
Immune system disorder
Injection site pain
Insomnia (sleeplessness)
Intervertebral disc protrusion (spinal disc protrusion)
Iron deficiency anaemia
Fatigue (feeling of tiredness)
Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
Drug ineffective

male:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Anaemia (lack of blood)
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Insomnia (sleeplessness)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Polyarthralgia (joint pain)
Thirst
Thrombocytopenia (decrease of platelets in blood)
Erythema (redness of the skin)

What are the common drug interactions of Nasacort and Zomig, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Fatigue (feeling of tiredness)
Anxiety disorder
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthma
Blood cholesterol increased
Cardiac disorder
Cardiac failure congestive
Chest pain
Depression

50-59:

Dizziness
Renal failure (kidney dysfunction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Bone density decreased
Dyspnoea (difficult or laboured respiration)
Emotional distress
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Insomnia (sleeplessness)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Osteopenia (a condition where bone mineral density is lower than normal)

60+:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Anaemia (lack of blood)
Pyrexia (fever)
Arthralgia (joint pain)
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Polyarthralgia (joint pain)
Thrombocytopenia (decrease of platelets in blood)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 18 people, 46.15%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 23.08%
High Blood Pressure: 4 people, 10.26%
Pain: 3 people, 7.69%
High Blood Cholesterol: 3 people, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.13%
Nasopharyngitis (inflammation of the nasopharynx): 2 people, 5.13%
Hypersensitivity: 2 people, 5.13%
Hiv Infection: 2 people, 5.13%
Headache (pain in head): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Nasacort and Zomig?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously